Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vision Sensing Acquisition Corp. is a special purpose acquisition company (SPAC) established to acquire or combine with private technology businesses. It is currently in the process of merging with Mediforum, a Korea-based biotech company, focusing on ethical drugs and diagnostics. VSAC itself has no current clinical programs or assets—it exists solely as an acquisition vehicle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vision Sensing Acquisition.